Pulmonary Drug Delivery Devices In-Depth Industrial studies with Latest and Advance Market Trends, - Global Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024
 |
| Pulmonary Drug Delivery Devices |
Albany, New York, Mar 24, 2017
"Pulmonary
Drug Delivery Devices Market - Global Industry Analysis, Size, Share,
Growth, Trends, and Forecast 2017 - 2024"
The Report covers current Industries Trends, Worldwide Analysis,
Global Forecast, Review, Share, Size, Growth, Effect.
Description-
Global
Pulmonary Drug Delivery Devices Market: Overview
This report on pulmonary drug delivery devices
studies the current as well as future prospects of the market
globally. The stakeholders of this report include companies and
intermediaries engaged in the manufacture and commercialization of
various pulmonary/respiratory drugs and/or drug-device combinations
as well as new entrants planning to enter this market.
This
report comprises an elaborate executive summary along with a market
snapshot providing overall information of various segments and
sub-segments considered within the scope of the study. This section
also provides the overall information and data analysis of the global
pulmonary drug delivery devices market with respect to the leading
market segments based on major products, key applications,
distribution channels, and geographies.
– Global Pulmonary Drug Delivery
Devices Market: Segmentation
The global pulmonary drug delivery devices market
has been studied based on major product type, application segments,
major distribution channels, and regional as well as national
markets. Based on product type, the global market has been
categorized into three major segments: Dry Powder Inhalers, Metered
Dose Inhalers and Nebulizers. Based on application, the global market
has been categorized into four segments: Asthma, COPD, cystic
fibrosis, and others. Based on distribution channels, the global
market has been categorized into three key segments: retail
pharmacies, hospital pharmacies, and e-commerce.
The market for these segments has been extensively
analyzed based on their utility, effectiveness, sales, and geographic
presence. Market revenue in terms of US$ Mn for the period from 2014
to 2024 along with the compound annual growth rate (CAGR %) from 2017
to 2024 are provided for all segments, considering 2015 as the base
year.
The market overview section of the report explores
the market dynamics such as drivers, restraints, and opportunities
that currently have a strong impact on the global pulmonary drug
delivery devices market and could influence the market in the near
future. Market attractiveness analysis has been provided in all the
sections of the report in order to explain the intensity of
competition in the market across different products / applications /
distribution channels / geographies.
– Global Pulmonary Drug Delivery
Devices Market: Regional Overview
Geographically, the pulmonary drug delivery
devices market has been segmented into five regions: North America,
Europe, Asia Pacific, Latin America, and Middle East & Africa
(MEA). Each regional market for pulmonary drug delivery devices
market has been further categorized into major product, application,
and end-user segments considered within the scope of the study.
Key country (U.S., Japan, Germany, France, U.K.,
Australia, Canada, China, Brazil, Mexico, India, etc.) market
revenues have also been provided in different regional sections
within the report. Market revenue in terms of US$ Mn for the period
from 2014 to 2024 along with CAGR % from 2017 to 2024 are provided
for all the regions and nations considering 2015 as the base year.
– Global Pulmonary Drug Delivery
Devices Market: Competitive Outlook
The competitive scenario among different market
players is evaluated through market share analysis in the competition
landscape section of the pulmonary drug delivery devices market
report. The section also includes competition matrix that analyzes
the competition among some of the top global players operating in the
market. All these factors would help market players to take strategic
decisions in order to strengthen their positions and expand their
shares in the global pulmonary drug delivery devices market.
The report also profiles key players operating in
the pulmonary drug delivery devices market based on various
attributes such as company details, SWOT analysis, strategic
overview, financials, and business overview. Major players profiled
in this report include AstraZeneca plc, Novartis AG, F. Hoffmann-La
Roche Ltd, GlaxoSmithKline plc, Merck & Co., Inc, Teva
Pharmaceutical Industries Ltd., Boehringer Ingelheim GmbH, 3M
Healthcare, Omron Corporation, and others.
** The global pulmonary drug delivery devices
market has been segmented as follows:
– By Product type
- Dry Powder Inhalers
- Single-dose inhalers
- Multi-dose inhalers
- Metered Dose Inhalers
- Manually-actuated pressurized inhaler
- Breath-actuated pressurized inhaler
- Nebulizers
- Jet nebulizers
- Ultrasonic wave nebulizers
- Vibrating mesh nebulizers
– By Application
- Asthma
- COPD
- Cystic Fibrosis
- Others
– By Distribution Channel
- Retail Pharmacies
- Hospital Pharmacies
- E-commerce
– By Geography
- North America
- US
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia & New Zealand
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East and Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Comments
Post a Comment